Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies
The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where…
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s…